Plaque Psoriasis

14 competing products in clinical development for Plaque Psoriasis.

Pipeline by Phase

Phase 13

Phase 24

Phase 34

Approved3

All Products (14)

Product	Company	Stage	Status	Hype
CT-P55 + EU-approved Cosentyx	Celltrion	Phase 3	Active	44
alefacept	Astellas Pharma	Approved	Completed	43
Topicort® (desoximetasone) Topical Spray, 0.25%	Sun Pharmaceutical	Approved	Completed	43
DSXS + Placebo	Sun Pharmaceutical	Phase 3	Completed	40
Tildrakizumab 200 mg + Tildrakizumab 100 mg + Matching Placebo	Sun Pharmaceutical	Phase 3	Completed	40
Tildrakizumab 200 mg + Tildrakizumab 100 mg + Tildrakizumab Placebo + Etanercept Placebo + Etanercept 50 mg	Sun Pharmaceutical	Phase 3	Completed	40
DSXS	Sun Pharmaceutical	Phase 2	Completed	35
DSXS topical	Sun Pharmaceutical	Phase 2	Completed	35
Halobetasol Topical Lotion	Sun Pharmaceutical	Approved	Terminated	35
DSXS1411 + Placebo	Sun Pharmaceutical	Phase 2	Completed	35
Topical TA-102 A + Topical TA-102 B + Topical TA-102 C + Topical TA-102 D + Topical TA-102 E	Sun Pharmaceutical	Phase 1	Completed	29
Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% + Duobrii® Lotion (Halobetasol propionate and tazarotene lotion), 0.01%/0.045% + Placebo	Sun Pharmaceutical	Phase 1	Completed	29
ONO-4685 + Placebo + ONO-4685 + Placebo + ONO-4685 + Placebo	Ono Pharmaceutical	Phase 1	Completed	29
Halobetasol Propionate	Sun Pharmaceutical	Phase 2	Withdrawn	27